Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 309.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.50 (0.82%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 309.00
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

1 Aug 2007 07:01

Morgan Crucible Co PLC01 August 2007 THE MORGAN CRUCIBLE COMPANY PLC ("MORGAN CRUCIBLE") ACQUIRES A 49% STAKE IN NP AEROSPACE Morgan Crucible is pleased to announce that it has acquired a 49% equity stakein NP Aerospace from the Carlyle Group and from management. The transactionvalues NP Aerospace at £71m including fees and is expected to be immediatelyearnings enhancing for Morgan Crucible. NP Aerospace is a composite technical moulding business that develops,manufactures and markets ballistic and non-ballistic products in the defence andcivil sectors. It is based in Coventry, UK with 200 employees and has a strongposition in the UK with the Ministry of Defence. NP Aerospace has a high degreeof experience and expertise in vehicle armour and enjoys unique areas ofapplication know-how in products such as military helmets and blast protectionsuits. Management will initially retain a 51% equity stake and a phased process is inplace for Morgan Crucible to acquire a further 21% of the equity after threeyears and move to full ownership in the three years thereafter. The initial 49%equity stake values NP Aerospace at 6.5 times 2006 EBITDA. The considerationpayable for the future equity purchases will be based on 7.25 times the EBITDAof the company for the calendar year preceding the date of each purchase. Mark Robertshaw, Chief Executive Officer of Morgan Crucible, said:"I am delighted to welcome NP Aerospace to the Group. This acquisition supportsour strategy of finding businesses that will enhance our existing core productranges. NP Aerospace will supplement our strong materials capability andsignificant geographic reach. Its committed team with their unique knowledgewill play a vital role in developing and expanding our presence within thedefence market." Mark Lejman, Director of Morgan Crucible and head of Morgan Crucible Armour, said: "This transaction with NP, coming on the back of investments in ceramicmaterials technology, further strengthens Morgan Crucible's commitment in the UKto finding innovative solutions for ballistic protection in the field of bothbody armour and vehicle armour." Notes for Class 2 purposes: The initial investment from Morgan Crucible will be £41.0 million structured as£36m in a shareholder loan paying 10% per annum, £4.5m in preference sharesyielding 8% per annum, and £0.5m for ordinary equity. NP Aerospace managementare also contributing £4.5m in preference shares and £0.5m of ordinary equity. In 2006 NP Aerospace revenues were £46.0 million and EBITDA £11.0 million, amargin of 23.7%. Profit before tax for 2006 was £5.4m. As at 31st December 2006NP Aerospace had gross assets of £39.8 million.(All the above numbers are quoted from statutory accounts based on UK GAAP) Enquiries: Victoria Gould The Morgan Crucible Company plc 01753 837306 Robin Walker Finsbury 020 7251 3801 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd May 20245:17 pmRNSDirector/PDMR Shareholding
10th May 20245:21 pmRNSDirector/PDMR Shareholding
9th May 20241:59 pmRNSResult of AGM
9th May 20247:00 amRNSQ1 Trading Update
1st May 20245:38 pmRNSHolding(s) in Company
24th Apr 20247:00 amRNSCapital Markets Update
5th Apr 202412:55 pmRNSAnnual Financial Report
4th Apr 20241:16 pmRNSDirector/PDMR Shareholding
27th Mar 20244:52 pmRNSDirector/PDMR Shareholding
27th Mar 20244:50 pmRNSDirector/PDMR Shareholding
27th Mar 20244:49 pmRNSDirector/PDMR Shareholding
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
14th Mar 20249:42 amRNSDirector/PDMR Shareholding
14th Mar 20249:41 amRNSDirector/PDMR Shareholding
13th Mar 202412:10 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSMorgan Advanced Materials Full Year 2023 Results
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
19th Dec 20231:56 pmRNSDirector/PDMR Shareholding
18th Dec 20234:25 pmRNSBlock listing Interim Review
22nd Nov 202310:07 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSQ3 Trading Update
9th Oct 20234:43 pmRNSDirector/PDMR Shareholding
26th Sep 202312:24 pmRNSDirector/PDMR Shareholding
16th Aug 202311:27 amRNSDirector/PDMR Shareholding
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20237:00 amRNSHalf-Year Results for Period Ended 30 June 2023
13th Jul 20234:49 pmRNSDirector/PDMR Shareholding
5th Jul 20234:51 pmRNSDirector/PDMR Shareholding
29th Jun 20235:06 pmRNSResult of AGM
29th Jun 20237:00 amRNSH1 Trading Update
22nd Jun 202311:50 amRNSBlock listing Interim Review
31st May 20233:52 pmRNSDirector/PDMR Shareholding
26th May 20233:28 pmRNSNotice of Annual General Meeting 2023
24th May 20233:59 pmRNSDirector/PDMR Shareholding
11th May 202312:06 pmRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
11th May 202311:59 amRNSDirector/PDMR Shareholding
9th May 20235:59 pmRNSDirector/PDMR Shareholding
4th May 20235:28 pmRNSAnnual Report & Accounts 2022
3rd May 20235:38 pmRNSDirector/PDMR Shareholding
3rd May 20235:28 pmRNSDirector/PDMR Shareholding
28th Apr 20235:45 pmRNSInformation required by DTR 4.1
28th Apr 20237:00 amRNSFull-year results for the period ended 31 Dec 2022
13th Apr 20237:00 amRNSNotification of Full-Year Results
7th Feb 20237:00 amRNSUpdate on Trading and Cyber Security Incident
18th Jan 20237:00 amRNSAppointment of Chair Designate
10th Jan 20237:00 amRNSNotice of Cyber Security Incident
22nd Dec 202211:01 amRNSBlock listing Interim Review
16th Dec 20224:44 pmRNSHolding(s) in Company
6th Dec 20227:00 amRNSAccelerated Pension Contribution

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.